Medical Technology: Entering a Billion-Dollar Market: Siemens Healthineers Pushes the Use of Brain Implants
The Dax group is working together with the US company Paradromics to advance the use of brain-computer interfaces as therapy. The technology is still in the research stage.
Siemens Healthineers has partnered with US-based neurotechnology company Paradromics to advance the use of brain implants. The two companies plan to develop an imaging platform for brain-computer interfaces that will cover the entire treatment process. Paradromics' founder and CEO Matt Angle emphasizes the importance of precise placement of brain-computer interfaces, as brain areas can vary from person to person.
The platform aims to improve the effectiveness of brain implants, which can enable people with paralysis to control devices with their thoughts.
Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
